Stock HOWL WEREWOLF THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
3.99 USD -22.82% Intraday chart for Werewolf Therapeutics, Inc. -18.24% +3.37%
Jun. 01 Werewolf Therapeutics to Present Data from Ongoing Phase 1/1B Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors CI
May. 23 Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting CI

Evolution of the average Target Price on Werewolf Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cfe3.o2PlLJ8kTvFLFnJgwWurRUpW1rLladjfQ8-Kk5oOqi0.1C-8aal9D4ApOxVT9j7gEQsYkcvcAr-dCaH6qsJ63Uf5K6Jk8HQ2qx9nEQ~56f0efb405a59ffdfb0ef95f3385dedd

Analyst Recommendations on Werewolf Therapeutics, Inc.

JMP Securities Starts Werewolf Therapeutics With Market Outperform Rating, $12 Price Target MT
Wedbush Starts Werewolf Therapeutics at Outperform With $9 Price Target MT
EF Hutton Starts Werewolf Therapeutics at Buy With $8.30 Price Target MT
History shows stocks can weather rate hike cycle RE
SVB Leerink Adjusts Werewolf Therapeutics' Price Target to $28 from $29, Keeps Outperform Rating MT
WEREWOLF THERAPEUTICS : BofA Securities Initiates Coverage on Werewolf Therapeutics With Buy Rating, $26 Price Target MT
WEREWOLF THERAPEUTICS : Evercore ISI Group Initiates Werewolf Therapeutics at Outperform With $23 Price Target MT
WEREWOLF THERAPEUTICS : SVB Leerink Initiates Coverage on Werewolf Therapeutics With Outperform Rating, $29 Price Target MT
WEREWOLF THERAPEUTICS : HC Wainwright Starts Werewolf Therapeutics at Buy With $32 Price Target MT
WEREWOLF THERAPEUTICS : Jefferies Starts Werewolf Therapeutics at Buy With $22 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
3.99 USD
Average target price
12.5 USD
Spread / Average Target
+213.28%
High Price Target
15 USD
Spread / Highest target
+275.94%
Low Price Target
9 USD
Spread / Lowest Target
+125.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Werewolf Therapeutics, Inc.

JMP Securities
Wedbush
EF Hutton
SVB Leerink
BofA Securities
Jefferies & Co.
HC Wainwright
Evercore ISI

Ratings for Werewolf Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HOWL Stock
  4. Consensus Werewolf Therapeutics, Inc.